Ozempic Injection, Solution
Product Images NDC 50090-5949

101 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 101 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 50090-5949). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structural_formula (Image 01)

Structural_formula (Image 01)
Chemical structure diagram of semaglutide, the active ingredient in Ozempic 1.34 mg/mL injection solution. The diagram shows the molecular structure with amino acid residues and chemical bonds typical for a peptide-based drug.*
FDA Label Image

Figure_1 (Image 02)

Figure_1 (Image 02)
A line graph depicting plasma glucose levels (mg/dL) over 24 hours after a breakfast meal. The graph compares baseline and treated subjects using Ozempic (semaglutide) at 0.5 mg and 1 mg doses, and placebo groups, illustrating the glucose changes for each treatment group over time.*
FDA Label Image

Figure_2 (Image 03)

Figure_2 (Image 03)
Line graph depicting insulin secretion rate (pmol/kg/min) as a function of plasma glucose levels (mg/dL) for different groups including CCEMPC baseline, CCEMPC 1 mg end of treatment, placebo end of treatment, placebo baseline, and healthy subjects. The graph shows comparative insulin secretion trends across these groups over the plasma glucose range from 90 to 210 mg/dL.*
FDA Label Image

Figure_3 (Image 04)

Figure_3 (Image 04)
A forest plot chart showing relative exposure (Cavg) ratios and 90% confidence intervals for semaglutide by intrinsic factors including sex, age groups (65-74 years, >74 years), race (Black or African American, Asian), ethnicity (Hispanic or Latino), body weight (55 kg, 127 kg), and renal impairment levels (mild, moderate, severe). The graph compares exposure against a reference subject profile with average semaglutide concentration.*
FDA Label Image

Figure_4 (Image 05)

Figure_4 (Image 05)
A forest plot chart showing relative exposure ratios and 90% confidence intervals for various co-administered medications with Ozempic (semaglutide). The medications listed include Metformin, S-warfarin, R-warfarin, Digoxin, Atorvastatin, Ethinylestradiol, and Levonorgestrel. All medications show a recommendation of no dose adjustment based on their exposure ratios near 1.0.*
FDA Label Image

Figure_5 (Image 06)

Figure_5 (Image 06)
A line graph showing changes in HbA1c percentage over 56 weeks post randomization for three groups: Ozempic 0.5 mg, Ozempic 1 mg, and Sitagliptin. The graph includes sample size numbers at various time points and indicates observed mean HbA1c with dropout multiple imputation estimates, including standard error bars at week 56.*
FDA Label Image

Figure_6 (Image 71)

Figure_6 (Image 71)
A Kaplan-Meier curve graph comparing the percentage of patients with events over time in weeks from randomization between Ozempic and placebo groups. The graph shows two lines, with Ozempic having a lower event rate than placebo. The hazard ratio is 0.74 with a 95% confidence interval of 0.58 to 0.95. Patient risk numbers at different time points are displayed below the graph for both groups.*
FDA Label Image

Image_121 (Image 07)

Image_121 (Image 07)
Ozempic 1.34 mg/mL injection solution for subcutaneous use in a pre-filled pen device. The label shows dosage strength and route, with packaging highlighting the product name, strength, and manufacturer A-S Medication Solutions.*
FDA Label Image

Image_122 (Image 08)

Image_122 (Image 08)
An instructional illustration showing the components and features of the Ozempic pen and NovoFine Plus needle. It labels parts such as the pen cap, pen window, dose counter, dose selector, dose button, and flow check symbol. Needle components including outer needle cap, inner needle cap, needle, and paper tab are also identified. The diagram notes the location of the expiration date and lot number on the pen label.*
FDA Label Image

Image_123 (Image 09)

Image_123 (Image 09)
An instructional illustration depicting a person using a pen-style injector. The image shows a hand gripping the device, positioned to remove or adjust a cap or cover, likely demonstrating preparation steps for subcutaneous injection.*
FDA Label Image

Image_124 (Image 10)

Image_124 (Image 10)
An instructional illustration showing a hand holding a syringe with the needle cap being removed, indicating preparation for injection.*
FDA Label Image

Image_125 (Image 11)

Image_125 (Image 11)
An instructional illustration showing how to prepare a subcutaneous injection. It depicts a hand holding an injection device with an arrow indicating a push or pull action, likely demonstrating how to remove a cap or attach a needle before injection.*
FDA Label Image

Image_126 (Image 12)

Image_126 (Image 12)
An instructional illustration showing a hand holding a pen-like injection device, demonstrating how to prepare or use the injection. The device appears to be for subcutaneous administration, consistent with an injectable solution product like Ozempic (semaglutide).*
FDA Label Image

Image_127 (Image 13)

Image_127 (Image 13)
An instructional diagram showing hands preparing an injection. One hand is holding a vial, and the other is attaching a needle to a syringe, illustrating the process of medication preparation for subcutaneous injection.*
FDA Label Image

Image_128 (Image 14)

Image_128 (Image 14)
An instructional illustration showing a close-up of a hand holding a vial or syringe with a needle being capped or uncapped. An arrow indicates the direction of movement for the needle cap. The image likely relates to preparation or administration of an injectable solution.*
FDA Label Image

Image_129 (Image 15)

Image_129 (Image 15)
Ozempic 1.34 mg/mL injection, solution in a subcutaneous prefilled pen displayed with its packaging carton. The label and carton show the proprietary name Ozempic and generic name semaglutide, with the labeler noted as A-S Medication Solutions. The carton includes usage instructions and dosage information in text.*
FDA Label Image

Image_flow_check_5 (Image 16)

Image_flow_check_5 (Image 16)
Ozempic 1.34 mg/mL injection, solution in a single-use prefilled pen. The label displays dosage form and strength with administration instructions. The labeler is A-S Medication Solutions, and the product NDC is 50090-5949.*
FDA Label Image

Image_130 (Image 17)

Image_130 (Image 17)
An instructional diagram showing a close-up view of an injection pen with a finger pressing a button. There is a flow check symbol visible near the pen's injection tip to indicate correct operation before use.*
FDA Label Image

Image_131 (Image 18)

Image_131 (Image 18)
Illustration showing the hands holding and preparing a semaglutide injection pen labeled as Ozempic 1.34 mg/mL. The image depicts the removal of the pen cap by pulling upwards, which is part of the injection preparation process for subcutaneous administration.*
FDA Label Image

Image_132 (Image 19)

Image_132 (Image 19)
Ozempic 1.34 mg/mL injection solution in a subcutaneous prefilled pen syringe. The label shows the brand name Ozempic, the active ingredient semaglutide, strength 1.34 mg/mL, and directions for once weekly use. The labeler is A-S Medication Solutions.*
FDA Label Image

Image_dose_counter_5 (Image 20)

Image_dose_counter_5 (Image 20)
Ozempic 1.34 mg/mL injection, solution, subcutaneous, single-dose pen cartridge packaging. The label includes the brand name Ozempic prominently, with the generic name semaglutide, and displays product information including strength and route of administration. The packaging is primarily white with purple and orange accents and shows the labeler as A-S Medication Solutions.*
FDA Label Image

Image_133 (Image 21)

Image_133 (Image 21)
An instructional illustration showing a close-up of a medication pen device. It highlights a display window with a dashed line indicating the selected dose of 1 mg. A finger is shown pulling a white cap off the pen, with an arrow pointing upward. The image guides the user on setting or confirming the dose selection on the pen for injection.*
FDA Label Image

Image_134 (Image 22)

Image_134 (Image 22)
Ozempic 1.34 mg/mL injection solution in a subcutaneous prefilled pen syringe. The label shows dosage strength and route, with branding and labeling by A-S Medication Solutions. The image captures the pen syringe device used for administering the medication.*
FDA Label Image

Image_135 (Image 23)

Image_135 (Image 23)
An instructional illustration showing a close-up of a hand pressing the dose counter stopper on a pen injector for subcutaneous injection. The image highlights the area to achieve the setting of 1 mg left on the dose counter for the Ozempic (semaglutide) injection, solution 1.34 mg/mL.*
FDA Label Image

Image_136 (Image 24)

Image_136 (Image 24)
An instructional anatomical illustration showing front and back views of a human body. It highlights recommended subcutaneous injection sites for Ozempic (semaglutide) injection, solution, 1.34 mg/mL by A-S Medication Solutions.*
FDA Label Image

Image_137 (Image 25)

Image_137 (Image 25)
An instructional illustration showing a hand holding a pen-like injection device with an arrow pointing downward, likely indicating how to prepare or use the device for subcutaneous injection.*
FDA Label Image

Image_138 (Image 26)

Image_138 (Image 26)
An instructional diagram showing a hand holding an injection device with a downward arrow indicating the direction to press or inject. The illustration emphasizes the technique for administering a subcutaneous injection using the device.*
FDA Label Image

Image_139 (Image 27)

Image_139 (Image 27)
Illustration showing a hand holding an injection pen and a speech bubble with the text "Count slowly: 1-2-3-4-5-6," indicating instructions for counting during administration.*
FDA Label Image

Image_140 (Image 28)

Image_140 (Image 28)
An instructional diagram showing a close-up of a pen-style injection device with an arrow pointing upwards, suggesting the action of removing a cap or needle cover. The illustration is likely related to the preparation or administration of an injectable medication.*
FDA Label Image

Image_141 (Image 29)

Image_141 (Image 29)
Ozempic 1.34 mg/mL injection, solution for subcutaneous use in a pen injector device. The label shows branding, dosage strength, and usage instructions for the single-dose pen. The labeler is A-S Medication Solutions. The NDC 50090-5949 is displayed on the packaging label.*
FDA Label Image

Image_142 (Image 30)

Image_142 (Image 30)
An instructional illustration depicting a hand removing or unlocking a cap from the top of a medication injection device, indicated by an arrow showing the direction to pull or twist the cap off. This image relates to proper preparation or assembly of the injection pen for subcutaneous use.*
FDA Label Image

Image_143 (Image 31)

Image_143 (Image 31)
An instructional illustration showing a vial and a cap being removed or placed onto the vial, indicating how to open or close the vial cap before use.*
FDA Label Image

Image_144 (Image 32)

Image_144 (Image 32)
An instructional illustration showing a close-up of hands preparing a prefilled injection pen. One hand is holding the pen while the other hand is twisting the pen's cap, indicating the step to remove or attach the cap before injection.*
FDA Label Image

Image_145 (Image 33)

Image_145 (Image 33)
An instructional illustration showing how to attach or detach a device component, with arrows indicating the direction of movement. The image appears to demonstrate part of device assembly or use, related to the Ozempic injection solution.*
FDA Label Image

Image_146 (Image 34)

Image_146 (Image 34)
Ozempic 1.34 mg/mL injection, solution for subcutaneous use in a 2 mL prefilled pen. The label includes the product name, strength, dosage form, the labeler A-S Medication Solutions, and usage instructions visible on the pen. This is a human prescription drug.*
FDA Label Image

Image_147 (Image 35)

Image_147 (Image 35)
The image shows the packaging label for Ozempic 1.34 mg/mL solution injection. It includes the product name, semaglutide as the generic ingredient, subcutaneous route, and is labeled by A-S Medication Solutions. The label also contains dosage form and strength details, with a focus on the product's identity and usage information.*
FDA Label Image

Image_148 (Image 36)

FDA Label Image

Image_149 (Image 37)

FDA Label Image

Image_61 (Image 38)

Image_61 (Image 38)
Ozempic 1.34 mg/mL injection solution for subcutaneous use in a glass vial. The label shows the brand name Ozempic and the active ingredient semaglutide. Labeler A-S Medication Solutions is identified. The vial contains 1.34 mg/mL concentration and includes dosage and use instructions on the label.*
FDA Label Image

Image_62 (Image 39)

Image_62 (Image 39)
An instructional diagram showing parts of an Ozempic pen and NovoFine Plus needle, including the pen cap, pen window, dose counter, dose pointer, dose selector, dose button, outer needle cap, inner needle cap, needle, and paper tab. It also highlights the location for expiration date and lot number, plus symbols for flow check and dashed line for dose guidance.*
FDA Label Image

Image_63 (Image 40)

Image_63 (Image 40)
An instructional illustration showing hands preparing a prefilled injection pen by attaching a needle. This image is related to the use of Ozempic (semaglutide) injection, solution, for subcutaneous administration.*
FDA Label Image

Image_64 (Image 41)

Image_64 (Image 41)
An instructional illustration showing a close-up of a hand holding a syringe or injection pen, indicating preparation or use of the device for subcutaneous injection. The image is simplified with blue and white colors, emphasizing the gripping and positioning of the injection device.*
FDA Label Image

Image_65 (Image 42)

Image_65 (Image 42)
An instructional diagram showing a close-up of hands preparing an injection pen, with one hand holding and the other manipulating a component, indicated by a black arrow pointing upwards.*
FDA Label Image

Image_66 (Image 43)

Image_66 (Image 43)
An instructional illustration showing a close-up of a hand holding an injection pen for subcutaneous administration. The image depicts the hand pressing or preparing the injection pen, likely demonstrating how to use the Ozempic (semaglutide) injection pen correctly.*
FDA Label Image

Image_67 (Image 44)

Image_67 (Image 44)
An instructional illustration showing a hand holding a syringe and a vial, demonstrating the process of removing a needle cap or preparing the injection. The image emphasizes safe handling of the injection equipment for subcutaneous administration.*
FDA Label Image

Image_68 (Image 45)

Image_68 (Image 45)
Instructional illustration showing a syringe being prepared for injection. The image depicts a hand holding a vial or pen device with an arrow indicating the removal of a cap or needle cover. This is part of the preparation process for subcutaneous injection.*
FDA Label Image

Image_69 (Image 46)

Image_69 (Image 46)
Ozempic 1.34 mg/mL injection solution label for subcutaneous use from A-S Medication Solutions. The label is primarily white with purple text and includes the proprietary and generic names, strength, dosage form, and route. The labeler name and an NDC code (50090-5949) are also visible.*
FDA Label Image

Image_flow_check_3 (Image 47)

Image_flow_check_3 (Image 47)
Ozempic 1.34 mg/mL injection solution in a subcutaneous prefilled pen syringe. The label includes branding, dosage strength, and usage instructions with visual step-by-step graphics on how to administer the injection. The labeler is A-S Medication Solutions. The packaging is designed for patient use with detailed administration guidance.*
FDA Label Image

Image_70 (Image 48)

Image_70 (Image 48)
An instructional illustration showing a finger pressing a button on a device's display panel, with a flow check symbol selected on the screen, likely demonstrating part of the usage instructions for an injection device.*
FDA Label Image

Image_71 (Image 49)

Image_71 (Image 49)
An instructional illustration showing a hand holding an injection pen device, identified as part of a subcutaneous injection administration process. The illustration features an arrow pointing upward, indicating the direction for preparing or using the injection pen, likely related to the Ozempic (semaglutide) injection. No text is visible besides the image details.*
FDA Label Image

Image_72 (Image 50)

Image_72 (Image 50)
Ozempic 1.34 mg/mL injection, solution in a subcutaneous pen device. The label shows the product name, strength, dosage form, and route. The labeler is A-S Medication Solutions, and the product NDC is 50090-5949. The label also includes dosage instructions and usage information visible on the pen.*
FDA Label Image

Image_dose_counter_3 (Image 51)

Image_dose_counter_3 (Image 51)
Ozempic 1.34 mg/mL injection, solution in a single-dose pen with a 3 mL capacity. The label shows the A-S Medication Solutions logo and states the product is for subcutaneous use only. Packaging includes lot number, expiration date, and storage information, with a red cap on the pen.*
FDA Label Image

Image_73 (Image 52)

Image_73 (Image 52)
An instructional diagram showing how to select the dose in a medication pen, specifically indicating the dialed line for a 0.25 mg dose and an example of a 0.5 mg dose.*
FDA Label Image

Image_74 (Image 53)

Image_74 (Image 53)
Ozempic injection, solution in a prefilled pen, 1.34 mg/mL strength by A-S Medication Solutions. The label displays dosage form and strength clearly with brand and generic names. The background is white with blue and black text, showing the NDC 50090-5949 and instruction to read the package insert.*
FDA Label Image

Image_75 (Image 54)

Image_75 (Image 54)
An instructional illustration showing a hand holding a prefilled injection pen labeled 'Ozempic' with a dose counter displaying the number 2.5. The image demonstrates the correct method of preparing the pen for subcutaneous injection.*
FDA Label Image

Image_76 (Image 55)

Image_76 (Image 55)
An instructional illustration showing front and back views of a human torso with highlighted subcutaneous injection sites. The image indicates areas suitable for subcutaneous administration of medication, such as the abdomen and outer thighs.*
FDA Label Image

Image_77 (Image 56)

Image_77 (Image 56)
An instructional diagram showing a hand holding a pen-like injection device aimed at a skin fold on the abdomen. A downward arrow indicates the direction for injecting the solution subcutaneously, demonstrating proper injection technique for Ozempic (semaglutide) injection.*
FDA Label Image

Image_78 (Image 57)

Image_78 (Image 57)
An instructional diagram showing a right hand holding a pen-like injection device poised above a finger, illustrating the step of preparing or administering a subcutaneous injection with the device. The image includes an inset with a symbol resembling a small circle with a line, possibly indicating a device setting or component detail.*
FDA Label Image

Image_79 (Image 58)

Image_79 (Image 58)
An instructional illustration showing a hand holding a syringe-like injection pen with a speech bubble that reads, "Count slowly: 1-2-3-4-5-6." The image appears to guide users on timing or counting during injection.*
FDA Label Image

Image_80 (Image 59)

Image_80 (Image 59)
An instructional illustration showing a syringe with an arrow pointing upward, indicating the removal or attachment action of the needle or cap. The syringe is partially visible, and a curved surface is depicted below it, suggesting preparation or handling steps for injection.*
FDA Label Image

Image_81 (Image 60)

Image_81 (Image 60)
Ozempic 1.34 mg/mL injection solution for subcutaneous use is shown in plain white packaging with prominent black text. The label includes the product's proprietary and generic names, concentration strength, administration route, and the labeler, A-S Medication Solutions, alongside NDC 50090-5949. The label is minimalistic with clear, legible text.*
FDA Label Image

Image_82 (Image 61)

Image_82 (Image 61)
An instructional illustration showing a hand opening the cap of a vial or pen by twisting it off as indicated by an arrow. The image is intended to demonstrate how to remove the cap from an injection vial or pen device for subcutaneous administration.*
FDA Label Image

Image_83 (Image 62)

Image_83 (Image 62)
An instructional diagram showing a vial with a flip-off cap being removed by lifting it upward, demonstrating how to access the vial's rubber stopper for subcutaneous injection preparation.*
FDA Label Image

Image_84 (Image 63)

Image_84 (Image 63)
An instructional illustration showing a person holding a pen injector device with one hand and using the other hand to peel off or remove a protective cap or cover from the needle end of the injector. The image demonstrates the preparation step before a subcutaneous injection.*
FDA Label Image

Image_85 (Image 64)

Image_85 (Image 64)
An instructional diagram showing the assembly of an injection device, specifically depicting alignment of needle components for a subcutaneous injection. The illustration includes arrows indicating the connection points of the injection device parts, likely related to Ozempic (semaglutide) injection use.*
FDA Label Image

Image_86 (Image 65)

Image_86 (Image 65)
Ozempic 1.34 mg/mL injection, solution for subcutaneous use supplied by A-S Medication Solutions. The label indicates it is a human prescription drug with the active ingredient semaglutide. The packaging shows a single-use pen injector device with branding and dosing information visible.*
FDA Label Image

Image_87 (Image 66)

Image_87 (Image 66)
Ozempic 1.34 mg/mL injection, solution in a 1.5 mL multi-dose pen. The label features the brand name Ozempic prominently with dosage strength and prescribing information. It is labeled for subcutaneous use and manufactured by A-S Medication Solutions. The packaging includes detailed instructions and warnings printed on the pen container.*
FDA Label Image

Image_88 (Image 67)

FDA Label Image

Image_89 (Image 68)

FDA Label Image

Image_91 (Image 73)

Image_91 (Image 73)
Ozempic 1.34 mg/mL injection solution in a clear glass vial with a purple cap and purple label accents. The label includes the product name Ozempic, the active ingredient semaglutide, and dosing information. The vial is marked for subcutaneous use. The labeler is A-S Medication Solutions.*
FDA Label Image

Image_92 (Image 74)

Image_92 (Image 74)
Illustration of the Ozempic injection pen and NovoFine Plus needle components. The image labels parts of the Ozempic pen including pen cap, pen window, expiration date label area, dose counter, dose pointer, dose selector, and dose button. It also shows the needle assembly with outer needle cap, inner needle cap, needle, and paper tab. Additional labels indicate the flow check symbol and a dashed line used as a dose guide.*
FDA Label Image

Image_93 (Image 75)

Image_93 (Image 75)
An instructional illustration showing hands manipulating a pen injector, indicating how to prepare or adjust the Ozempic semaglutide injection device for subcutaneous use.*
FDA Label Image

Image_94 (Image 76)

Image_94 (Image 76)
An illustration showing a close-up of a hand holding a syringe-type injector pen, likely for the subcutaneous injection of Ozempic (semaglutide) 1.34 mg/mL solution. The image highlights the injector pen's body and needle tip protector.*
FDA Label Image

Image_95 (Image 77)

Image_95 (Image 77)
An instructional illustration showing a hand removing or twisting a cap, likely from a medication pen or injection device, indicated by an arrow pointing counterclockwise. The image appears to be part of a step-by-step guide for preparing an injection device, possibly related to Ozempic injection solution.*
FDA Label Image

Image_96 (Image 78)

Image_96 (Image 78)
Illustration showing a hand holding an Ozempic injection pen and preparing it for use, likely demonstrating the step to remove or adjust the pen cap before injection.*
FDA Label Image

Image_97 (Image 79)

Image_97 (Image 79)
An instructional illustration showing a close-up of a hand attaching a needle cap or connector to a pen-style injection device, indicated by an arrow pointing towards the connection point.*
FDA Label Image

Image_98 (Image 80)

Image_98 (Image 80)
An instructional illustration showing a hand holding a cap being removed from the tip of a pen-style injection device. The image includes a directional arrow indicating the direction to pull the cap away from the device.*
FDA Label Image

Image_99 (Image 81)

Image_99 (Image 81)
Ozempic 1.34 mg/mL injection solution for subcutaneous use in a prefilled pen device carton. The label displays the product name, strength, dosage form, route of administration, and indicates it contains 2 mL of solution. The labeler is A-S Medication Solutions.*
FDA Label Image

Image_flow_check_4 (Image 82)

Image_flow_check_4 (Image 82)
Ozempic 1.34 mg/mL injection solution in a glass vial with a blue cap. The label shows the product name Ozempic, active ingredient semaglutide, and strength 1.34 mg/mL. Manufactured by A-S Medication Solutions.*
FDA Label Image

Image_100 (Image 83)

Image_100 (Image 83)
An instructional illustration showing a close-up of a hand holding a pen injector device set for Ozempic injection solution. The image highlights the flow check symbol selection on the device, indicating proper preparation for subcutaneous injection.*
FDA Label Image

Image_101 (Image 84)

Image_101 (Image 84)
Illustration showing a hand holding a pen-style injection device, likely depicting the preparation or use step for a subcutaneous injection. The device has a cap on the needle end and an arrow indicating to pull or remove the cap upward. A close-up inset of the needle cap is included in the top right corner.*
FDA Label Image

Image_102 (Image 85)

Image_102 (Image 85)
Ozempic 1.34 mg/mL injection, solution for subcutaneous use packaging label. The label shows the product name Ozempic and the active ingredient semaglutide. The labeler is A-S Medication Solutions and the NDC is 50090-5949. The image depicts a medication vial with a white and yellow label.*
FDA Label Image

Image_dose_counter_4 (Image 86)

Image_dose_counter_4 (Image 86)
The image shows the Ozempic injection solution packaging, labeled with the proprietary name Ozempic and the generic name semaglutide. It is a subcutaneous injection solution with a strength of 1.34 mg/mL. The labeler listed on the package is A-S Medication Solutions. The product NDC is 50090-5949.*
FDA Label Image

Image_103 (Image 87)

Image_103 (Image 87)
An instructional diagram demonstrating the adjustment of dosing on an injection device for Ozempic (semaglutide) 1.34 mg/mL. The image shows a hand turning the dose selector with detailed callouts indicating a dashed line and the selection of the 2 mg dose for subcutaneous injection.*
FDA Label Image

Image_104 (Image 88)

Image_104 (Image 88)
Ozempic 1.34 mg/mL injection solution for subcutaneous use, supplied in a pre-filled pen device. The label shows the brand name Ozempic and active ingredient semaglutide. The product is labeled by A-S Medication Solutions with Product NDC 50090-5949. This packaging is designed for a prescription human drug.*
FDA Label Image

Image_105 (Image 89)

Image_105 (Image 89)
An instructional illustration for Ozempic injection, solution, showing a hand holding the injection pen with a dose counter window depicting '0 mg' and a note indicating the dose counter stopped with 2 mg left to be administered.*
FDA Label Image

Image_106 (Image 90)

Image_106 (Image 90)
An instructional illustration showing the front and back views of a human body, highlighting possible injection sites for subcutaneous administration. The diagram indicates areas on the abdomen, thigh, and upper arm where injections may be given.*
FDA Label Image

Image_107 (Image 91)

Image_107 (Image 91)
An instructional illustration showing a hand holding a pen-like injection device with the needle pointing downward. A downward arrow indicates the direction for injecting, suggesting subcutaneous administration technique for the Ozempic injection solution.*
FDA Label Image

Image_108 (Image 92)

Image_108 (Image 92)
An instructional illustration showing a hand holding a prefilled Ozempic injection pen (semaglutide 1.34 mg/mL) with an arrow pointing downward to indicate pressing or injection direction. A blue square inset shows a dose window displaying "0 mg." This diagram depicts how to prepare or administer the subcutaneous injection.*
FDA Label Image

Image_109 (Image 93)

Image_109 (Image 93)
An instructional illustration showing a hand holding an injection pen vertically against the skin, with a speech bubble instructing to count slowly '1-2-3-4-5-6', indicating a timed action during administration.*
FDA Label Image

Image_110 (Image 94)

Image_110 (Image 94)
An instructional illustration showing a close-up of an injection pen needle with an upward arrow indicating the direction of removal or detachment, likely part of user guidance for the Ozempic injection pen device.*
FDA Label Image

Image_111 (Image 95)

Image_111 (Image 95)
Ozempic 1.34 mg/mL injection solution in a subcutaneous prefilled pen. The carton shows the brand name, dosage strength, route of administration, and contains one 2 mL pen. Labeler is A-S Medication Solutions.*
FDA Label Image

Image_112 (Image 96)

Image_112 (Image 96)
Instructional illustration showing a hand holding an Ozempic injection pen with an arrow indicating the removal of the pen cap by twisting or pulling it off, preparing for subcutaneous injection.*
FDA Label Image

Image_113 (Image 97)

Image_113 (Image 97)
An instructional diagram showing a vial with a rubber stopper being accessed by a needle or syringe. A downward arrow indicates the needle is intended to puncture the stopper, illustrating how to draw medication from the vial for injection.*
FDA Label Image

Image_114 (Image 98)

Image_114 (Image 98)
An instructional illustration depicting hands peeling back the protective seal from a pen injector device, likely demonstrating the preparation step for use before administration.*
FDA Label Image

Image_115 (Image 99)

Image_115 (Image 99)
An instructional illustration showing the assembly of an injection pen device. The image depicts a pen needle being aligned and attached to the pen injector by inserting the needle onto the pen with arrows indicating the direction of connection.*
FDA Label Image

Image_116 (Image 100)

Image_116 (Image 100)
Ozempic 1.34 mg/mL injection solution label for subcutaneous use. The label shows the proprietary name Ozempic prominently, the active ingredient semaglutide, the dosage strength of 1.34 mg/mL, and the product type as a human prescription drug. Labeled by A-S Medication Solutions with NDC 50090-5949.*
FDA Label Image

Image_117 (Image 101)

Image_117 (Image 101)
Ozempic 1.34 mg/mL injection solution, subcutaneous use, manufactured by A-S Medication Solutions. The label displays the product name, strength, dosage form, route, and labeler information clearly for this prescription drug.*
FDA Label Image

Image_118 (Image 104)

Image_118 (Image 104)
Illustration of the Ozempic pen and NovoFine Plus needle, showing labeled components including the pen cap, pen window, dose counter, dose pointer, dose selector, dose button, and needle parts such as outer and inner needle caps, needle, and paper tab. It also highlights the location of the expiration date on the pen label and the flow check symbol with a dashed line guide for dose setting.*
FDA Label Image

Image_119 (Image 105)

Image_119 (Image 105)
An instructional illustration showing hands pulling or twisting a part of an injection device. The image likely demonstrates preparation or assembly steps for using a subcutaneous injection product.*
FDA Label Image

Label Image (Lbl500905949)

Label Image (Lbl500905949)
Ozempic 1.34 mg/mL semaglutide injection solution label from A-S Medication Solutions. The label notes it is a prefilled pen containing 1.34 mg per mL with a warning not to freeze. It states the product contains 1 Ozempic pen with 4 nonviable plus 3 mg needles and includes a reference to the package insert for dosage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.